{
  "trial_id": "NCT00524134",
  "overall_assessment": "likely_eligible",
  "inclusion": [
    {
      "criterion": "probable or definite localization-related, primary generalized or symptomatic epilepsy",
      "label": "met",
      "evidence": "quote"
    },
    {
      "criterion": "generalized epilepsy that is medically-refractory",
      "label": "met",
      "evidence": "quote"
    },
    {
      "criterion": "at least 2 anti-epilepsy drugs at standard doses, despite medication compliance",
      "label": "met",
      "evidence": "quote"
    },
    {
      "criterion": "at least 3 seizures/month in the 3-month period prior to randomization",
      "label": "met",
      "evidence": "quote"
    },
    {
      "criterion": "history or symptoms of cardiovascular disease may be eligible on a case-by-case basis",
      "label": "unknown",
      "evidence": "none"
    }
  ],
  "exclusion": [
    {
      "criterion": "pregnancy or breast-feeding",
      "label": "not_met",
      "evidence": "quote"
    },
    {
      "criterion": "systolic blood pressure <100mmHg",
      "label": "unknown",
      "evidence": "none"
    }
  ],
  "notes": "41 year old man with history of severe intellectual disability, CHF, epilepsy presenting with facial twitching on the right and generalized shaking in at his NH which required 20 mg valium to cease seizure activity.",
  "_meta": {
    "topic_id": "9",
    "trial_id": "NCT00524134",
    "model": "llama3.1:8b",
    "run_tag": "llama31_8b_full_top100",
    "top_k": 100
  }
}